A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2) | MicrobiomeTrials

← Back to trials

NCT06951711

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2025-06-13Est. Completion: 2026-11-02

Enrollment target: 274 participants

Locations

Pillar Clinical Research- Little Rock, Little Rock, Arkansas, United States
Woodland Research Northwest, Rogers, Arkansas, United States
Proscience Research Group, Culver City, California, United States
Clinical Innovations, Inc. dba CITrials, Riverside, California, United States
Collaborative Neuroscience Research, LLC, Torrance, California, United States
Health Synergy Clinical Research, Boynton Beach, Florida, United States
Local Institution - 0036, Hialeah Gardens, Florida, United States
Behavioral Clinical Research, Hollywood, Florida, United States
LCC Medical Research Institute, Miami, Florida, United States
Innovative Clinical Research, Inc., Miami Lakes, Florida, United States
South Florida Research Phase I-IV, Miami Springs, Florida, United States
Local Institution - 0019, Tampa, Florida, United States
Atlanta Center for Medical Research, Atlanta, Georgia, United States
CenExel iResearch, LLC, Decatur, Georgia, United States
Local Institution - 0020, Chicago, Illinois, United States

Other microbiome trials you might be interested in

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)Phase 3Recruiting

Bipolar Disorder Type I With Mania

This is a phase 3, open-label extension study to assess the long-term safety of KarXT for the treatment of mania or mani…

Glendale, United StatesEst. completion Jun 13, 2028

Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9)Phase 4Recruiting

Depression, Bipolar

The goal is to study the effect of lithium compared to cariprazine in patients with depression in a bipolar disease. Th…

Aalborg, DenmarkEst. completion Sep 1, 2028

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.